Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
China - Hong Kong SAR 1996-200133090.681.375.592.586.183.280.381.8
China - Shangai 1992-199518987.874.065.989.778.773.471.073.7
China - Tianjin 1991-199914188.779.778.790.785.488.987.288.3
Pakistan - South Karachi 1995-19994686.460.641.688.464.845.744.443.0
Singapore 1993-19978785.175.965.086.679.069.263.070.1
Republic of Korea - Busan 1996-20018690.775.266.991.978.070.965.070.3
Republic of Korea - Incheon 1997-20014986.370.563.387.974.469.366.969.7
Republic of Korea - Seoul 1993-199719489.270.664.390.473.668.762.764.4
Thailand - Lampang 1990-20003284.459.459.485.261.062.048.850.9



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period